Vascular device market sluggish through 2016; China Medical files for bankruptcy;

 @FierceMedDev: Slow growth ahead for the vascular access device market? Release | Follow @FierceMedDev

 @MarkHFierce: Shire has regulatory approval in Canada for its new diabetic foot ulcer treatment. Item | Follow @MarkHFierce

 @DamianFierce: Roche is betting big on companion diagnostics for its pipeline drugs. Article | Follow @DamianFierce

> Expect slow growth for the vascular access device market at least through 2016, the Millennium Research Group concludes in a new report. Release

> LipoScience got 510(k) clearance for its Vantera clinical analyzer, a diagnostic designed to identify and quantify concentrations of lipoproteins to determine risk of heart disease. More

> Researchers in Germany have developed a device that allows patients to measure their glucose without needle pricks. Story

> Medtronic ($MDT) is pairing its new insulin pumps with Bayer's Contour Next Link wireless blood glucose meters. Article

> Oklahoma City's Orthocare Innovations will unveil its Magellan microprocessor foot ankle system prosthetic device at the American Orthotic and Prosthetic Association National Assembly to be held this week in Boston. Release

> NeuroSigma got a CE marking for Monarch, an external trigeminal nerve stimulation system made to treat epilepsy and major depressive disorder in adults and children 9 years and older. Item

> The Department of Justice and Centers for Medicare & Medicaid Services have sent guidelines to hospitals recommending they audit themselves to check if they have overbilled Medicare for implantable cardiac defibrillators. Report

Biotech News

 @FierceBiotech: Can a triple-play COPD drug protect GSK from Novartis' QVA149? Story | Follow @FierceBiotech

 @JohnCFierce: Orexigen says it will complete Contrave study enrollment later this year, interim analysis in 2013. Release | Follow @JohnCFierce

> Novartis bets big that canakinumab can conquer a vast cardio market. Article

> Intercept Pharma files for $75M IPO to back PhIII liver drug. News

> Roche spotlights top blockbuster bets as it showcases R&D. Report

> Pfizer wins FDA approval for orphan chronic myelogenous leukemia drug. Story

Pharma News

 @FiercePharma: Good news for pharma's stop-smoking products: Quitters are more successful with patches, drugs, study finds. More | Follow @FiercePharma

> JAMA says FDA jumped the gun on Gilenya, Pradaxa. Report

> Is the antidepressant glass half-empty or half-full? More

> European officials back HPV shots for all girls. Story

Biomarkers News

> Mesothelioma markers predict response to Alimta. Story

> Lab aims to pinpoint PTSD with biomarkers. News

> Merck Serono launches biomarker spinoff. More

> Researchers find new brain cancer target. Article

> 'Traffic light test' could spot liver disease earlier. Item

Drug Delivery News

> Nanoparticles protect heart and cut cancer drug resistance. Article

> Cross-shaped RNA carries drugs to cells. More

> Pulmatrix is breathing relief into COPD. Story

> University snags $2.6M for HIV nanodrug delivery. News

And Finally... Devicemaker China Medical Technologies has filed for Chapter 15 bankruptcy, claiming about $500 million in assets and debts. It's the latest news in the company's slow decline. In July, the SEC suspended the company from trading in the U.S. over concerns the company had falsified disclosures, and the firm's investors petitioned for liquidation back in June. News

Suggested Articles

The drug that treats atrial fibrillation, flecainide, has been around since the '80s. Grace Colón, CEO of InCarda, thinks it needs a face-lift.

3M, maker of the ubiquitous Littmann stethoscope brand, has teamed up with Eko to create a new digital version that amplifies sounds and adds AI.

Study data from Medtronic showed more patients reported improvements in their chronic back pain after treatments with the devicemaker’s tiny implant.